DSS anyone watching the action?

Seems like recent merger could be big deal.

Now steady downticks for a week with the share swap with merger company, etc...

Seems like it was forced down for a reason, now gonna bounce?

Lotta bulls out there, including Forbes:

http://www.forbes.com/sites/richardfinger/2012/10/15/just-another-lawsuit-against-facebook-maybe-not/

http://seekingalpha.com/article/910321-facebook-lawsuit-could-send-document-security-systems-share-price-soaring?

http://seekingalpha.com/article/912141-emerging-market-and-patent-lawsuit-make-document-security-systems-a-good-play?

Any opinions from you guys? Thanks!

DSS anyone watching the action?

Seems like recent merger could be big deal.

Now steady downticks for a week with the share swap with merger company, etc...

Seems like it was forced down for a reason, now gonna bounce?

Lotta bulls out there, including Forbes:

http://www.forbes.com/sites/richardfinger/2012/10/15/just-another-lawsuit-against-facebook-maybe-not/

http://seekingalpha.com/article/910321-facebook-lawsuit-could-send-document-security-systems-share-price-soaring?

http://seekingalpha.com/article/912141-emerging-market-and-patent-lawsuit-make-document-security-systems-a-good-play?

Any opinions from you guys? Thanks!

You're joking, right? 11-0 NO VOTE... This is garbage in the short term. Someone is squeezing it higher on air to set up a homerun short for themselves. Getting other huge shorts to cover some into the squeeze today.

.40 cents tops tonight

.25's hitting

$SGEN FDA approval. haha, nice $heff

Bought $IGXT today at .60 I like it here.

in $PATH here. Could move so nicely if vol comes in.

LONG $DVAX today. Reasoning here...

Dynavax DVAX is bio developing vaccines for infectious disease/auto-immune conditions.

- Late-stage vaccine is HEPLISAV (a hepatitis B virus/HBV vaccine)

- Phase 3 clinical trials due to report results in mid-late July.

In May, DVAX completed 12-month follow-up for Phase 3 clinical trial of vaccine for the prevention of hepatitis B infection in subjects w/ chronic kidney disease.

- Potential BLA filing during 4Q11.

- Plus the chart looks ripe for a move/bounce.

GLTA

FCSC climbing

Awesome post, $heff! Like usual. Great insight.

$AMRN wish I woulda held the swing on my own suggestion. haha

so is CRIS data out already then?

$AMRN first green day for awhile. Could be nice swing.

be nice to see $ACUR spike here at open north of $6

FCSC panic last couple days. Still long here.

TTNP ugh. Bought this one recently. What bad timing. Loss.

more news on that fwiw....

http://www.eurekalert.org/pub_releases/2011-06/uhcm-sfv060311.php

long $AGEN on news....

http://www.sciencedaily.com/releases/2011/06/110603111210.htm


Like these low prices.

stong label? what's with pps?

OPTR approved!

$ANX moving up today. I grabbed some.

Anyone watching $ANX at these levels?

agree. PATH with volume will send it much higher.

$NVAX, what's the board think of this one?

I have NO position, just seems like major support at $2, meanwhile I'm hearing lotta upside chatter.

Any opinion, $heff?

Thanks, guys.

$APRI. I'm long here. Rumors circulating of huge upside valuations. Worth the risk/reward i think.

LONG

$IRDM buyout speculation

$IRDM buyout speculation

FDA encourages MNKD ? ...

CEO says FDA sent letter of support, wants MNKD to get approval...

http://www.thescientifik.com/p/mannkind-corporation-mnkd.html

CEO: "Such a letter is highly unusual and we consider it still another signal that the FDA wants to help us reach approval of AFREZZA."

OPTR thinking swing into FDA here soon

OPTR nice action

XPRT book value supposedly $1?

The non-binding indication of interest sets the enterprise value of LECG at $104 million, on a cash free, debt free basis. This implies a value of up to $1 for each outstanding share of common stock after repayment of the Company's existing debt and redemption of the Company's Series A Convertible Redeemable Preferred Stock. Under the terms of the transaction contemplated by the indication of interest, any additional indebtedness incurred by the Company before the closing of the transaction will reduce the implied value of common stock in the transaction. The Company may incur such additional indebtedness to fund operations in the coming periods.


anyone know anything/truth to this??

XPRT $1 book value? ...

Not sure what to make of this...

The non-binding indication of interest sets the enterprise value of LECG at $104 million, on a cash free, debt free basis. This implies a value of up to $1 for each outstanding share of common stock after repayment of the Company's existing debt and redemption of the Company's Series A Convertible Redeemable Preferred Stock. Under the terms of the transaction contemplated by the indication of interest, any additional indebtedness incurred by the Company before the closing of the transaction will reduce the implied value of common stock in the transaction. The Company may incur such additional indebtedness to fund operations in the coming periods.

I've got a few calls. Would love a good news item.

DCTH fast-track status was rumored today but I can't remember the source. Anyone hearing that?

MCZ Microsoft deal.

DEPO approved!

sorry, i got out awhile back.

sold CLDA this week. ha

CPD I'm long. Heard they won this case vs. Novo pharma...

Any thoughts?

http://www.mied.uscourts.gov/Opinions/cohnpdf/05-40188.pdf

funny timing. I just read an article in Wired magazine about this company (CYTX) yesterday and started investigating it myself. Was going to bring it to the board but it doesnt' look like the greatest "trader" imo. But long term, who knows. Anyone else with thoughts?